Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes, diabetes, and controls from a general population without cardiovascular disease

PloS One
Sophia D HeberFabian Bamberg

Abstract

Despite the relevance of pancreatic fat content in the development of metabolic diseases, its association with impaired glucose metabolism, diabetes, and other adipose tissue compartments remains unclear. Thus, we determined differences in pancreatic fat content by magnetic resonance imaging (MRI) between subjects with prediabetes, diabetes, and normal controls in a cohort from the general population. Subjects without history of cardiovascular disease with established diabetes or prediabetes as well as normal controls were included and underwent whole-body MRI on a 3T scanner. Pancreatic fat content was quantified by measuring the proton-density fat fraction (PDFFpanc) using a 3D multi-echo GRE sequence (increment: 1.23 ms, 6 echoes) by placing ROIs in the pancreatic head, body, and tail by independent readers. In addition, hepatic fat content as well as abdominal subcutaneous and visceral adipose tissue (SAT and VAT) were measured by multi-echo GRE and 3D 2-point volume-interpolated DIXON MRI, respectively. Univariate and multivariate analyses were employed to determine associations. A total of 385 subjects were included in the analysis (median age: 57 years, 58.2% males), of them 53 were classified as subjects with diabetes, ...Continue Reading

References

Jul 21, 2005·Das Gesundheitswesen·R HolleUNKNOWN MONICA/KORA Study Group
Jan 29, 2008·Current Diabetes Reviews·Ute M Schaefer-Graf, Helmut Kleinwechter
Mar 12, 2008·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Henry A Pitt
May 30, 2009·Journal of the American College of Surgeons·Abhishek MathurKeith D Lillemoe
Jan 26, 2010·Journal of Magnetic Resonance Imaging : JMRI·Christian WürslinFritz Schick
Nov 26, 2010·Magnetic Resonance Imaging Clinics of North America·Scott B Reeder, Claude B Sirlin
Apr 28, 2011·Gastrointestinal Endoscopy·Paul S SepeMandeep S Sawhney
Sep 20, 2012·JAMA : the Journal of the American Medical Association·Ian J NeelandJames A de Lemos
May 15, 2013·PloS One·Horng-Yih OuChih-Jen Chang
Dec 19, 2013·Gastroenterology Research and Practice·Niraj S PatelRohit Loomba
Feb 5, 2014·The American Journal of Gastroenterology·Vincent Wai-Sun WongHenry Lik-Yuen Chan
Apr 9, 2014·BMC Public Health·Esther RufUNKNOWN MONICA/KORA investigators
Oct 20, 2014·Reviews in Endocrine & Metabolic Disorders·Patrick MathieuJean-Pierre Després
May 2, 2015·The Journal of Clinical Investigation·Ulf Smith
Mar 22, 2016·JRSM Cardiovascular Disease·Thang S Han, Mike Ej Lean

❮ Previous
Next ❯

Citations

Apr 26, 2019·Nutrients·Yixin JiangJohanna Nattenmüller
Apr 16, 2019·The British Journal of Radiology·Manil D ChouhanStuart A Taylor
Mar 1, 2019·Investigative Radiology·Marie-Luise KromreyJens-Peter Kühn
Jun 28, 2018·The Journal of Clinical Endocrinology and Metabolism·Daniel PoppNora N Sommer
Nov 6, 2018·Scientific Reports·Vinciane ReboursAnne Couvelard
Feb 1, 2019·Journal of Magnetic Resonance Imaging : JMRI·Yesenia CovarrubiasClaude B Sirlin
Feb 6, 2020·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Beate FischerMichael F Leitzmann
Jun 6, 2018·The British Journal of Radiology·Naomi S SakaiManil D Chouhan
Apr 4, 2021·Nutrients·Marta Sánchez On Behalf Of The Ilervas Project Collaborators
Jun 22, 2021·Clinical and Experimental Gastroenterology·Celal UlasogluArda Yavuz
Jun 29, 2021·Endocrine Reviews·Steven E KahnC Bruce Verchere

❮ Previous
Next ❯

Software Mentioned

Stata
Syngo Via

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.